Ray Browning
CEO & Co-Founder

The startup develops robotic exoskeletons that assist individuals with mobility challenges due to neurologic disorders such as stroke and cerebral palsy. Their wearable systems provide real-time training insights, tele-rehabilitation compatibility, and progress reporting to enhance therapeutic outcomes and improve walking ability.
Raised to date
$3.5MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Individuals with neurological disorders such as stroke and cerebral palsy often experience mobility challenges, leading to reduced walking ability and diminished quality of life. Conventional gait training methods may not provide sufficient stimulus or repetition to maximize recovery, resulting in limited progress towards functional goals. Patient fatigue and poor walking mechanics can further hinder effective rehabilitation.
Biomotum provides robotic exoskeletons, specifically the SPARK AFO (ankle-foot orthosis) system, designed to assist and restore walking function for individuals with mobility impairments. The wearable systems deliver precise, on-demand joint torque at the ankle, providing assistance or resistance during ambulation. The SPARK system is untethered, allowing for use on various terrains, and offers real-time training insights and performance feedback through a dedicated mobile app. By increasing gait quality, treatment dose, and therapeutic impact, Biomotum's technology aims to improve patient outcomes and enhance overall mobility.
The primary target audience includes individuals with gait impairments due to neurological or orthopedic conditions, physical therapists seeking advanced rehabilitation tools, and clinical researchers studying human ambulation and movement disorders.